Fighting Chewing Gum Is Cut...
Researchers at the University of Pennsylvania have developed a bioengineered chewing gum designed to target microbes linked to head and neck cancers. Lab tests on oral samples showed it significantly reduced HPV and specific bacteria, aiming to provide a new, accessible treatment.
Why it matters
This innovation could offer a non-invasive, complementary approach to existing cancer therapies, potentially improving outcomes for patients with head and neck cancers by selectively targeting harmful microbes while preserving beneficial oral flora.
R esearchers at the University of Pennsylvania have developed a bioengineered chewing gum that could offer a surprisingly simple way to target microbes associated with head and neck cancers .
Tests using the specially engineered gum on oral samples from patients found that it reduced HPV levels by up to 93% and nearly eliminated two bacteria linked to head and neck cancer in laboratory tests.
The treatment delivers targeted biological agents directly in the mouth, potentially tackling cancer-associated viruses and bacteria without destroying the microbial communities that help keep the mouth healthy.
Maintaining beneficial bacteria in the mouth is increasingly recognised as important to both oral and overall health. Some cancer treatments can disrupt this microbial balance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in